Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
38
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Davarpanah Nicole Negar | Chief Medical Officer | 12 | $0 | $29.8K | 2026-01-07 |
| Merson James | Director | 6 | $0 | $0 | 2026-01-07 |
| Canale-Theakston Carin | Director | 14 | $0 | $0 | 2026-01-07 |
| Spencer Ryan | Director | 6 | $0 | $0 | 2026-01-07 |
| Resnick Joshua | Director | 4 | $0 | $0 | 2026-01-07 |
| Bassler Bonnie L | Director | 15 | $0 | $0 | 2026-01-07 |
| Ward Shane | COO & CLO | 27 | $0 | $2.25M | 2026-01-07 |
| Mineo Chrysa | Director | 23 | $73.9K | $0 | 2026-01-07 |
| Stein Jeffrey | President & CEO | 81 | $2.31M | $0 | 2026-01-07 |
| Schroeder Theodore R | Director | 23 | $0 | $0 | 2026-01-07 |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 10 | $0 | $0 | 2026-01-07 |
| KARBE FRANK | Chief Financial Officer | 6 | $0 | $0 | 2026-01-07 |
| BURGESS DANIEL D | Director | 25 | $48.0K | $0 | 2026-01-07 |
| Kolchinsky Peter | Director, 10% Owner | 5 | $100.00M | $0 | 2025-06-26 |
| Tari Leslie | Chief Scientific Officer | 20 | $9.7K | $120.8K | 2025-03-11 |
| Shah Rajeev M. | Director | 1 | $0 | $0 | 2025-01-03 |
| Shah Preetam | Chief Financial Officer | 17 | $30.8K | $34.9K | 2024-09-30 |
| Sandison Taylor | Chief Medical Officer | 45 | $118.0K | $66.0K | 2024-09-30 |
| Tadvalkar Laura | Director | 2 | $0 | $0 | 2024-07-18 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 1 | $0 | $0 | 2024-07-18 |
| Gollaher David L | Director | 6 | $0 | $0 | 2023-06-22 |
| Franson Timothy R | Director | 11 | $78.8K | $0 | 2023-06-22 |
| Daruwala Paul | Chief Operating Officer | 36 | $0 | $48.0K | 2022-09-12 |
| Johnson Brady | Vice President, Finance | 11 | $0 | $1.7K | 2022-03-31 |
| Oien Jessica | General Counsel & Secretary | 12 | $0 | $9.9K | 2021-04-01 |
| Abdollahian Neil | Chief Business Officer | 27 | $0 | $41.1K | 2021-04-01 |
| Levine James E. | Chief Financial Officer | 9 | $215.1K | $0 | 2021-03-17 |
| ROCKLAGE SCOTT M | Director, 10% Owner | 8 | $0 | $0 | 2018-06-13 |
| Onaitis Matthew | Gnrl Counsel, CFO & Secretary | 5 | $0 | $0 | 2018-03-29 |
| BIOTECH TARGET N V | 10% Owner | 1 | $454.2K | $0 | 2017-11-15 |
| Wilson Marc | Chief Accounting Officer | 4 | $0 | $0 | 2017-09-18 |
| PEREZ ROBERT J | Director | 4 | $80.0K | $0 | 2017-06-22 |
| Forrest Kevin | Chief Scientific Officer | 5 | $247.9K | $0 | 2017-03-31 |
| Bartizal Ken | Chief Development Officer | 2 | $0 | $0 | 2017-03-31 |
| Thye Dirk | Chief Medical Officer | 1 | $0 | $0 | 2016-03-16 |
| Kjellson Nina S | Director | 3 | $3.20M | $0 | 2015-04-20 |
| Heron Patrick J | Director | 6 | $3.20M | $0 | 2015-04-20 |
| ELMS STEVE | Director | 2 | $0 | $0 | 2015-04-20 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Davarpanah Nicole Negar | Chief Medical Officer | D To issuer deriv | 2026-01-07 | 2026-01-07 | 5,000 | — | $0 | 0 | SEC↗ |
| Davarpanah Nicole Negar | Chief Medical Officer | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,000 | — | $0 | 0 | SEC↗ |
| Davarpanah Nicole Negar | Chief Medical Officer | D To issuer deriv | 2026-01-07 | 2026-01-07 | 62,597 | — | $0 | 0 | SEC↗ |
| Davarpanah Nicole Negar | Chief Medical Officer | D To issuer deriv | 2026-01-07 | 2026-01-07 | 30,000 | — | $0 | 0 | SEC↗ |
| Davarpanah Nicole Negar | Chief Medical Officer | D To issuer deriv | 2026-01-07 | 2026-01-07 | 20,000 | — | $0 | 0 | SEC↗ |
| Ward Shane | COO & CLO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 135,540 | — | $0 | 0 | SEC↗ |
| Ward Shane | COO & CLO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 50,000 | — | $0 | 0 | SEC↗ |
| Ward Shane | COO & CLO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 12,499 | — | $0 | 0 | SEC↗ |
| Ward Shane | COO & CLO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 6,207 | — | $0 | 0 | SEC↗ |
| Ward Shane | COO & CLO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 12,500 | — | $0 | 0 | SEC↗ |
| KARBE FRANK | Chief Financial Officer | D To issuer deriv | 2026-01-07 | 2026-01-07 | 115,000 | — | $0 | 0 | SEC↗ |
| Stein Jeffrey | President & CEO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 26,249 | — | $0 | 0 | SEC↗ |
| Stein Jeffrey | President & CEO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 16,499 | — | $0 | 0 | SEC↗ |
| Stein Jeffrey | President & CEO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 13,249 | — | $0 | 0 | SEC↗ |
| Stein Jeffrey | President & CEO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,749 | — | $0 | 0 | SEC↗ |
| Stein Jeffrey | President & CEO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,000 | — | $0 | 0 | SEC↗ |
| Stein Jeffrey | President & CEO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 7,949 | — | $0 | 0 | SEC↗ |
| Stein Jeffrey | President & CEO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 275,000 | — | $0 | 0 | SEC↗ |
| Stein Jeffrey | President & CEO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 560,888 | — | $0 | 0 | SEC↗ |
| Stein Jeffrey | President & CEO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 51,999 | — | $0 | 0 | SEC↗ |
| Stein Jeffrey | President & CEO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 27,174 | — | $0 | 0 | SEC↗ |
| Stein Jeffrey | President & CEO | D To issuer deriv | 2026-01-07 | 2026-01-07 | 16,499 | — | $0 | 0 | SEC↗ |
| BURGESS DANIEL D | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| BURGESS DANIEL D | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 1,400 | — | $0 | 0 | SEC↗ |
| BURGESS DANIEL D | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| BURGESS DANIEL D | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| BURGESS DANIEL D | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| BURGESS DANIEL D | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| BURGESS DANIEL D | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| BURGESS DANIEL D | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 450 | — | $0 | 0 | SEC↗ |
| BURGESS DANIEL D | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,100 | — | $0 | 0 | SEC↗ |
| BURGESS DANIEL D | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 20,500 | — | $0 | 0 | SEC↗ |
| BURGESS DANIEL D | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| Schroeder Theodore R | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| Schroeder Theodore R | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| Schroeder Theodore R | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 20,500 | — | $0 | 0 | SEC↗ |
| Schroeder Theodore R | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,100 | — | $0 | 0 | SEC↗ |
| Schroeder Theodore R | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| Schroeder Theodore R | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| Schroeder Theodore R | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| Schroeder Theodore R | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 450 | — | $0 | 0 | SEC↗ |
| Schroeder Theodore R | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| Schroeder Theodore R | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| Schroeder Theodore R | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 1,400 | — | $0 | 0 | SEC↗ |
| Mineo Chrysa | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| Mineo Chrysa | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| Mineo Chrysa | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 1,400 | — | $0 | 0 | SEC↗ |
| Mineo Chrysa | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 1,000 | — | $0 | 0 | SEC↗ |
| Mineo Chrysa | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| Mineo Chrysa | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,100 | — | $0 | 0 | SEC↗ |
| Mineo Chrysa | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 19,000 | — | $0 | 0 | SEC↗ |
| Mineo Chrysa | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| Mineo Chrysa | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| Mineo Chrysa | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| Bassler Bonnie L | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 1,400 | — | $0 | 0 | SEC↗ |
| Bassler Bonnie L | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| Bassler Bonnie L | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| Bassler Bonnie L | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 16,000 | — | $0 | 0 | SEC↗ |
| Bassler Bonnie L | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,100 | — | $0 | 0 | SEC↗ |
| Bassler Bonnie L | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| Bassler Bonnie L | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 1,750 | — | $0 | 0 | SEC↗ |
| Canale-Theakston Carin | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 1,750 | — | $0 | 0 | SEC↗ |
| Canale-Theakston Carin | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| Canale-Theakston Carin | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 1,400 | — | $0 | 0 | SEC↗ |
| Canale-Theakston Carin | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| Canale-Theakston Carin | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| Canale-Theakston Carin | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 16,000 | — | $0 | 0 | SEC↗ |
| Canale-Theakston Carin | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,100 | — | $0 | 0 | SEC↗ |
| Merson James | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,100 | — | $0 | 0 | SEC↗ |
| Merson James | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| Merson James | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 4,250 | — | $0 | 0 | SEC↗ |
| Spencer Ryan | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 4,250 | — | $0 | 0 | SEC↗ |
| Spencer Ryan | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| Spencer Ryan | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,100 | — | $0 | 0 | SEC↗ |
| Resnick Joshua | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 5,079 | — | $0 | 0 | SEC↗ |
| Resnick Joshua | Director | D To issuer deriv | 2026-01-07 | 2026-01-07 | 22,200 | — | $0 | 0 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | D To issuer deriv | 2026-01-07 | 2026-01-09 | 22,200 | — | $0 | 0 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | D To issuer deriv | 2026-01-07 | 2026-01-09 | 89,956 | $15505.00 | $1.39B | 0 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | M Exercise deriv | 2026-01-07 | 2026-01-09 | 1,286,786 | — | $0 | 0 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | D To issuer deriv | 2026-01-07 | 2026-01-09 | 5,079 | — | $0 | 0 | SEC↗ |
| Davarpanah Nicole Negar | Chief Medical Officer | D To issuer | 2026-01-07 | 2026-01-07 | 8,333 | — | $0 | 0 | SEC↗ |
| Davarpanah Nicole Negar | Chief Medical Officer | D To issuer | 2026-01-07 | 2026-01-07 | 12,553 | $221.50 | $2.78M | 8,333 | SEC↗ |
| Ward Shane | COO & CLO | D To issuer | 2026-01-07 | 2026-01-07 | 25,083 | $221.50 | $5.56M | 0 | SEC↗ |
| KARBE FRANK | Chief Financial Officer | D To issuer | 2026-01-07 | 2026-01-07 | 43,125 | — | $0 | 0 | SEC↗ |
| KARBE FRANK | Chief Financial Officer | D To issuer | 2026-01-07 | 2026-01-07 | 7,526 | $221.50 | $1.67M | 43,125 | SEC↗ |
| Stein Jeffrey | President & CEO | D To issuer | 2026-01-07 | 2026-01-07 | 2,379 | $221.50 | $526.9K | 0 | SEC↗ |
| Stein Jeffrey | President & CEO | D To issuer | 2026-01-07 | 2026-01-07 | 67,498 | $221.50 | $14.95M | 0 | SEC↗ |
| Stein Jeffrey | President & CEO | D To issuer | 2026-01-07 | 2026-01-07 | 5,763 | $221.50 | $1.28M | 0 | SEC↗ |
| BURGESS DANIEL D | Director | D To issuer | 2026-01-07 | 2026-01-07 | 150 | $221.50 | $33.2K | 0 | SEC↗ |
| Mineo Chrysa | Director | D To issuer | 2026-01-07 | 2026-01-07 | 3,320 | $221.50 | $735.4K | 0 | SEC↗ |
| Bassler Bonnie L | Director | D To issuer | 2026-01-07 | 2026-01-07 | 15 | $221.50 | $3.3K | 0 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | D To issuer | 2026-01-07 | 2026-01-09 | 4,652,309 | $221.50 | $1.03B | 0 | SEC↗ |
| RA Capital Healthcare Fund LP | Director, 10% Owner | M Exercise | 2026-01-07 | 2026-01-09 | 1,286,786 | — | $0 | 4,652,309 | SEC↗ |
| Davarpanah Nicole Negar | Chief Medical Officer | G Gift | 2025-12-29 | 2025-12-29 | 450 | — | $0 | 20,886 | SEC↗ |
| Stein Jeffrey | President & CEO | G Gift | 2025-12-22 | 2025-12-29 | 5,425 | — | $0 | 65,109 | SEC↗ |
| Stein Jeffrey | President & CEO | G Gift | 2025-12-19 | 2025-12-29 | 10,638 | — | $0 | 10,295 | SEC↗ |
| Stein Jeffrey | President & CEO | G Gift | 2025-12-19 | 2025-12-29 | 10,638 | — | $0 | 70,534 | SEC↗ |
| Stein Jeffrey | President & CEO | G Gift | 2025-12-17 | 2025-12-29 | 2,244 | — | $0 | 20,883 | SEC↗ |
| Stein Jeffrey | President & CEO | G Gift | 2025-12-17 | 2025-12-29 | 2,244 | — | $0 | 59,896 | SEC↗ |
| Ward Shane | COO & CLO | M Exercise deriv | 2025-12-10 | 2025-12-12 | 3,500 | — | $0 | 0 | SEC↗ |
| Ward Shane | COO & CLO | M Exercise deriv | 2025-12-10 | 2025-12-12 | 6,459 | — | $0 | 6,207 | SEC↗ |
| Davarpanah Nicole Negar | Chief Medical Officer | F Tax w/h | 2025-12-10 | 2025-12-12 | 10,332 | $219.60 | $2.27M | 21,286 | SEC↗ |
| Ward Shane | COO & CLO | M Exercise | 2025-12-10 | 2025-12-12 | 6,459 | $20.20 | $130.5K | 34,592 | SEC↗ |
| Ward Shane | COO & CLO | M Exercise | 2025-12-10 | 2025-12-12 | 3,500 | $16.65 | $58.3K | 28,133 | SEC↗ |
| Ward Shane | COO & CLO | F Tax w/h | 2025-12-10 | 2025-12-12 | 15,041 | $219.60 | $3.30M | 24,633 | SEC↗ |
| Ward Shane | COO & CLO | S Sale | 2025-12-10 | 2025-12-12 | 9,959 | $220.08 | $2.19M | 25,033 | SEC↗ |
| KARBE FRANK | Chief Financial Officer | F Tax w/h | 2025-12-10 | 2025-12-12 | 7,290 | $219.60 | $1.60M | 50,562 | SEC↗ |
| Stein Jeffrey | President & CEO | F Tax w/h | 2025-12-10 | 2025-12-12 | 2,285 | $219.60 | $501.8K | 56,199 | SEC↗ |
| Stein Jeffrey | President & CEO | G Gift | 2025-12-10 | 2025-12-29 | 33,072 | — | $0 | 23,127 | SEC↗ |
| Stein Jeffrey | President & CEO | G Gift | 2025-12-10 | 2025-12-29 | 33,072 | — | $0 | 57,652 | SEC↗ |
| Davarpanah Nicole Negar | Chief Medical Officer | S Sale | 2025-09-11 | 2025-09-15 | 474 | $62.86 | $29.8K | 31,418 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | P Buy | 2025-06-26 | 2025-06-30 | 2,272,727 | $44.00 | $100.00M | 3,365,523 | SEC↗ |
| Bassler Bonnie L | Director | A Award deriv | 2025-06-18 | 2025-06-18 | 11,100 | — | $0 | 11,100 | SEC↗ |
| BURGESS DANIEL D | Director | A Award deriv | 2025-06-18 | 2025-06-18 | 11,100 | — | $0 | 11,100 | SEC↗ |
| Canale-Theakston Carin | Director | A Award deriv | 2025-06-18 | 2025-06-18 | 11,100 | — | $0 | 11,100 | SEC↗ |
| Merson James | Director | A Award deriv | 2025-06-18 | 2025-06-18 | 11,100 | — | $0 | 11,100 | SEC↗ |
| Mineo Chrysa | Director | A Award deriv | 2025-06-18 | 2025-06-18 | 11,100 | — | $0 | 11,100 | SEC↗ |
| Schroeder Theodore R | Director | A Award deriv | 2025-06-18 | 2025-06-18 | 11,100 | — | $0 | 11,100 | SEC↗ |
| Spencer Ryan | Director | A Award deriv | 2025-06-18 | 2025-06-18 | 11,100 | — | $0 | 11,100 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2025-06-18 | 2025-06-18 | 5,079 | — | $0 | 5,079 | SEC↗ |
| Kolchinsky Peter | Director | A Award deriv | 2025-06-18 | 2025-06-18 | 5,079 | — | $0 | 5,079 | SEC↗ |
| Mineo Chrysa | Director | P Buy | 2025-06-03 | 2025-06-04 | 1,050 | $23.44 | $24.6K | 3,320 | SEC↗ |
| Mineo Chrysa | Director | P Buy | 2025-06-02 | 2025-06-04 | 2,270 | $21.71 | $49.3K | 2,270 | SEC↗ |
| Davarpanah Nicole Negar | Chief Medical Officer | A Award deriv | 2025-05-01 | 2025-05-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Davarpanah Nicole Negar | Chief Medical Officer | A Award | 2025-05-01 | 2025-05-12 | 10,000 | — | $0 | 31,692 | SEC↗ |
| Ward Shane | COO & CLO | A Award deriv | 2025-03-31 | 2025-04-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Stein Jeffrey | President & CEO | A Award deriv | 2025-03-31 | 2025-04-02 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Ward Shane | COO & CLO | A Award | 2025-03-31 | 2025-04-02 | 25,000 | — | $0 | 39,674 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-03-11 | 2025-03-13 | 1,773 | $21.96 | $38.9K | 16,215 | SEC↗ |
| Ward Shane | COO & CLO | S Sale | 2025-03-11 | 2025-03-13 | 1,664 | $21.96 | $36.5K | 14,674 | SEC↗ |
| KARBE FRANK | Chief Financial Officer | A Award deriv | 2025-02-24 | 2025-02-26 | 115,000 | — | $0 | 115,000 | SEC↗ |
| KARBE FRANK | Chief Financial Officer | A Award | 2025-02-24 | 2025-02-26 | 57,500 | — | $0 | 57,500 | SEC↗ |
| Shah Rajeev M. | Director | A Award deriv | 2025-01-03 | 2025-01-07 | 22,200 | — | $0 | 22,200 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2025-01-03 | 2025-01-07 | 22,200 | — | $0 | 22,200 | SEC↗ |
| Canale-Theakston Carin | Director | A Award deriv | 2024-12-17 | 2024-12-19 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Bassler Bonnie L | Director | A Award deriv | 2024-12-17 | 2024-12-19 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Mineo Chrysa | Director | A Award deriv | 2024-12-17 | 2024-12-19 | 19,000 | — | $0 | 19,000 | SEC↗ |
| Schroeder Theodore R | Director | A Award deriv | 2024-12-17 | 2024-12-19 | 20,500 | — | $0 | 20,500 | SEC↗ |
| BURGESS DANIEL D | Director | A Award deriv | 2024-12-17 | 2024-12-19 | 20,500 | — | $0 | 20,500 | SEC↗ |
| Kolchinsky Peter | Director | A Award deriv | 2024-11-26 | 2024-11-29 | 1,286,786 | $14.91 | $19.19M | 1,286,786 | SEC↗ |
| Kolchinsky Peter | Director | A Award | 2024-11-26 | 2024-11-29 | 389,716 | $14.91 | $5.81M | 1,092,796 | SEC↗ |
| Ward Shane | COO & CLO | A Award deriv | 2024-09-30 | 2024-10-02 | 135,540 | — | $0 | 135,540 | SEC↗ |
| Shah Preetam | Chief Financial Officer | A Award deriv | 2024-09-30 | 2024-10-02 | 130,087 | — | $0 | 130,087 | SEC↗ |
| Stein Jeffrey | President & CEO | A Award deriv | 2024-09-30 | 2024-10-02 | 560,888 | — | $0 | 560,888 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2024-09-30 | 2024-10-02 | 150,224 | — | $0 | 150,224 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | A Award deriv | 2024-09-30 | 2024-10-02 | 166,836 | — | $0 | 166,836 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | S Sale | 2024-09-11 | 2024-09-13 | 909 | $11.64 | $10.6K | 17,788 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | S Sale | 2024-09-11 | 2024-09-13 | 924 | $11.64 | $10.8K | 23,067 | SEC↗ |
| RA Capital Healthcare Fund LP | Director | C Conversion deriv | 2024-07-19 | 2024-07-22 | 10,044 | — | $0 | 89,956 | SEC↗ |
| RA Capital Healthcare Fund LP | Director | C Conversion | 2024-07-19 | 2024-07-22 | 703,080 | — | $0 | 703,080 | SEC↗ |
| Tadvalkar Laura | Director | A Award deriv | 2024-07-18 | 2024-07-19 | 2,125 | — | $0 | 2,125 | SEC↗ |
| Spencer Ryan | Director | A Award deriv | 2024-07-18 | 2024-07-19 | 2,125 | — | $0 | 2,125 | SEC↗ |
| Schroeder Theodore R | Director | A Award deriv | 2024-07-18 | 2024-07-19 | 2,125 | — | $0 | 2,125 | SEC↗ |
| Mineo Chrysa | Director | A Award deriv | 2024-07-18 | 2024-07-19 | 2,125 | — | $0 | 2,125 | SEC↗ |
| Merson James | Director | A Award deriv | 2024-07-18 | 2024-07-19 | 2,125 | — | $0 | 2,125 | SEC↗ |
| Canale-Theakston Carin | Director | A Award deriv | 2024-07-18 | 2024-07-19 | 2,125 | — | $0 | 2,125 | SEC↗ |
| Bassler Bonnie L | Director | A Award deriv | 2024-07-18 | 2024-07-19 | 2,125 | — | $0 | 2,125 | SEC↗ |
| BURGESS DANIEL D | Director | A Award deriv | 2024-07-18 | 2024-07-19 | 2,125 | — | $0 | 2,125 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director | A Award deriv | 2024-07-18 | 2024-07-19 | 2,125 | — | $0 | 2,125 | SEC↗ |
| Kolchinsky Peter | Director | A Award deriv | 2024-07-18 | 2024-07-22 | 2,125 | — | $0 | 2,125 | SEC↗ |
| RA Capital Healthcare Fund LP | Director | A Award deriv | 2024-07-18 | 2024-07-22 | 100,000 | $1000.00 | $100.00M | 100,000 | SEC↗ |
| Stein Jeffrey | President & CEO | P Buy | 2024-06-07 | 2024-06-11 | 8,000 | $13.21 | $105.7K | 24,580 | SEC↗ |
| Tadvalkar Laura | Director | A Award deriv | 2024-04-26 | 2024-04-30 | 4,250 | — | $0 | 4,250 | SEC↗ |
| Merson James | Director | A Award deriv | 2024-04-26 | 2024-04-30 | 4,250 | — | $0 | 4,250 | SEC↗ |
| Spencer Ryan | Director | A Award deriv | 2024-04-26 | 2024-04-30 | 4,250 | — | $0 | 4,250 | SEC↗ |
| RA Capital Healthcare Fund LP | Director | A Award deriv | 2024-04-26 | 2024-04-30 | 4,250 | — | $0 | 4,250 | SEC↗ |
| Stein Jeffrey | President & CEO | A Award deriv | 2024-03-15 | 2024-03-20 | 1,040,000 | — | $0 | 1,040,000 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | A Award deriv | 2024-03-15 | 2024-03-20 | 235,500 | — | $0 | 235,500 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2024-03-15 | 2024-03-20 | 222,500 | — | $0 | 222,500 | SEC↗ |
| Shah Preetam | CFO & CBO | A Award deriv | 2024-03-15 | 2024-03-20 | 217,500 | — | $0 | 217,500 | SEC↗ |
| Ward Shane | COO & CLO | A Award deriv | 2024-03-15 | 2024-03-20 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | A Award | 2024-03-15 | 2024-03-20 | 128,750 | — | $0 | 475,845 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | A Award | 2024-03-15 | 2024-03-20 | 111,250 | — | $0 | 369,931 | SEC↗ |
| Shah Preetam | CFO & CBO | A Award | 2024-03-15 | 2024-03-20 | 108,750 | — | $0 | 335,960 | SEC↗ |
| Ward Shane | COO & CLO | A Award | 2024-03-15 | 2024-03-20 | 120,000 | — | $0 | 318,770 | SEC↗ |
| Shah Preetam | CFO & CBO | S Sale | 2024-03-11 | 2024-03-12 | 18,931 | $0.67 | $12.7K | 227,210 | SEC↗ |
| Ward Shane | COO & CLO | S Sale | 2024-03-11 | 2024-03-12 | 20,473 | $0.67 | $13.7K | 198,770 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | S Sale | 2024-03-11 | 2024-03-12 | 20,662 | $0.67 | $13.8K | 347,095 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | S Sale | 2024-03-11 | 2024-03-12 | 21,029 | $0.67 | $14.1K | 258,681 | SEC↗ |
| Stein Jeffrey | President & CEO | F Tax w/h | 2024-03-11 | 2024-03-12 | 56,692 | $0.69 | $39.1K | 1,153,693 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | S Sale | 2023-09-11 | 2023-09-13 | 18,793 | $0.95 | $17.9K | 363,757 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | S Sale | 2023-09-11 | 2023-09-13 | 18,469 | $0.95 | $17.5K | 275,710 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | P Buy | 2023-08-14 | 2023-08-14 | 10,000 | $0.97 | $9.7K | 294,179 | SEC↗ |
| Stein Jeffrey | President & CEO | P Buy | 2023-08-08 | 2023-08-08 | 50,000 | $0.96 | $48.0K | 331,602 | SEC↗ |
| Gollaher David L | Director | A Award deriv | 2023-06-22 | 2023-06-23 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Bassler Bonnie L | Director | A Award deriv | 2023-06-22 | 2023-06-23 | 42,500 | — | $0 | 42,500 | SEC↗ |
| BURGESS DANIEL D | Director | A Award deriv | 2023-06-22 | 2023-06-23 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Franson Timothy R | Director | A Award deriv | 2023-06-22 | 2023-06-23 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Schroeder Theodore R | Director | A Award deriv | 2023-06-22 | 2023-06-23 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Canale-Theakston Carin | Director | A Award deriv | 2023-06-22 | 2023-06-23 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Mineo Chrysa | Director | A Award deriv | 2023-06-22 | 2023-06-23 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Shah Preetam | CFO & CBO | A Award deriv | 2023-03-27 | 2023-03-29 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2023-03-27 | 2023-03-29 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | A Award deriv | 2023-03-27 | 2023-03-29 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Stein Jeffrey | President & CEO | A Award deriv | 2023-03-27 | 2023-03-29 | 543,500 | — | $0 | 543,500 | SEC↗ |
| Ward Shane | COO & CLO | A Award deriv | 2023-03-27 | 2023-03-29 | 253,333 | — | $0 | 253,333 | SEC↗ |
| Stein Jeffrey | President & CEO | P Buy | 2023-03-27 | 2023-03-27 | 50,000 | $1.04 | $52.0K | 281,602 | SEC↗ |
| Shah Preetam | CFO & CBO | A Award | 2023-03-27 | 2023-03-29 | 90,000 | — | $0 | 238,141 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | A Award | 2023-03-27 | 2023-03-29 | 90,000 | — | $0 | 280,179 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | A Award | 2023-03-27 | 2023-03-29 | 90,000 | — | $0 | 378,550 | SEC↗ |
| Stein Jeffrey | President & CEO | A Award | 2023-03-27 | 2023-03-29 | 271,750 | — | $0 | 1,202,385 | SEC↗ |
| Ward Shane | COO & CLO | A Award | 2023-03-27 | 2023-03-29 | 126,667 | — | $0 | 211,243 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | S Sale | 2023-03-13 | 2023-03-13 | 7,203 | $1.53 | $11.0K | 288,550 | SEC↗ |
| Shah Preetam | CFO & CBO | S Sale | 2023-03-13 | 2023-03-13 | 6,648 | $1.53 | $10.2K | 148,141 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | S Sale | 2023-03-13 | 2023-03-13 | 7,562 | $1.53 | $11.6K | 190,179 | SEC↗ |
| Ward Shane | COO & CLO | S Sale | 2023-03-13 | 2023-03-13 | 4,329 | $1.53 | $6.6K | 84,576 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | S Sale | 2023-01-12 | 2023-01-27 | 11,814 | $1.20 | $14.2K | 1,484 | SEC↗ |
| Shah Preetam | CFO & CBO | S Sale | 2022-09-19 | 2022-09-19 | 15,642 | $0.77 | $12.0K | 150,789 | SEC↗ |
| Shah Preetam | CFO & CBO | M Exercise deriv | 2022-09-15 | 2022-09-19 | 50,000 | — | $0 | 0 | SEC↗ |
| Shah Preetam | CFO & CBO | M Exercise | 2022-09-15 | 2022-09-19 | 50,000 | — | $0 | 166,431 | SEC↗ |
| Daruwala Paul | Chief Operating Officer | S Sale | 2022-09-12 | 2022-09-13 | 16,199 | $0.68 | $11.0K | 221,099 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | S Sale | 2022-09-12 | 2022-09-13 | 18,159 | $0.68 | $12.3K | 193,741 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | S Sale | 2022-09-12 | 2022-09-13 | 18,478 | $0.68 | $12.6K | 291,753 | SEC↗ |
| Canale-Theakston Carin | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 28,000 | — | $0 | 28,000 | SEC↗ |
| Gollaher David L | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 28,000 | — | $0 | 28,000 | SEC↗ |
| Mineo Chrysa | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 28,000 | — | $0 | 28,000 | SEC↗ |
| Schroeder Theodore R | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 28,000 | — | $0 | 28,000 | SEC↗ |
| Bassler Bonnie L | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 28,000 | — | $0 | 28,000 | SEC↗ |
| BURGESS DANIEL D | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 28,000 | — | $0 | 28,000 | SEC↗ |
| Franson Timothy R | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 28,000 | — | $0 | 28,000 | SEC↗ |
| Daruwala Paul | Chief Operating Officer | A Award deriv | 2022-03-31 | 2022-04-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2022-03-31 | 2022-04-04 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Stein Jeffrey | President & CEO | A Award deriv | 2022-03-31 | 2022-04-04 | 330,000 | — | $0 | 330,000 | SEC↗ |
| Ward Shane | CHIEF LEGAL OFFICER | A Award deriv | 2022-03-31 | 2022-04-04 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | A Award deriv | 2022-03-31 | 2022-04-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Shah Preetam | CFO & CBO | A Award deriv | 2022-03-31 | 2022-04-04 | 102,500 | — | $0 | 102,500 | SEC↗ |
| Johnson Brady | Vice President, Finance | A Award deriv | 2022-03-31 | 2022-04-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Daruwala Paul | Chief Operating Officer | A Award | 2022-03-31 | 2022-04-04 | 50,000 | — | $0 | 237,298 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | A Award | 2022-03-31 | 2022-04-04 | 52,500 | — | $0 | 207,900 | SEC↗ |
| Stein Jeffrey | President & CEO | A Award | 2022-03-31 | 2022-04-04 | 165,000 | — | $0 | 654,878 | SEC↗ |
| Stein Jeffrey | President & CEO | F Tax w/h | 2022-03-31 | 2022-04-04 | 140,985 | $0.83 | $117.0K | 922,635 | SEC↗ |
| Stein Jeffrey | President & CEO | A Award | 2022-03-31 | 2022-04-04 | 408,742 | — | $0 | 1,063,620 | SEC↗ |
| Ward Shane | CHIEF LEGAL OFFICER | F Tax w/h | 2022-03-31 | 2022-04-04 | 23,122 | $0.83 | $19.2K | 80,905 | SEC↗ |
| Ward Shane | CHIEF LEGAL OFFICER | A Award | 2022-03-31 | 2022-04-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Ward Shane | CHIEF LEGAL OFFICER | A Award | 2022-03-31 | 2022-04-04 | 69,027 | — | $0 | 104,027 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | A Award | 2022-03-31 | 2022-04-04 | 50,000 | — | $0 | 306,231 | SEC↗ |
| Shah Preetam | CFO & CBO | A Award | 2022-03-31 | 2022-04-04 | 51,250 | — | $0 | 71,250 | SEC↗ |
| Shah Preetam | CFO & CBO | F Tax w/h | 2022-03-31 | 2022-04-04 | 24,820 | $0.83 | $20.6K | 112,431 | SEC↗ |
| Shah Preetam | CFO & CBO | A Award | 2022-03-31 | 2022-04-04 | 66,001 | — | $0 | 137,251 | SEC↗ |
| Johnson Brady | Vice President, Finance | A Award | 2022-03-31 | 2022-04-04 | 10,000 | — | $0 | 59,366 | SEC↗ |
| Johnson Brady | Vice President, Finance | S Sale | 2022-03-21 | 2022-03-23 | 654 | $0.81 | $530 | 49,366 | SEC↗ |
| Johnson Brady | Vice President, Finance | S Sale | 2022-03-11 | 2022-03-11 | 945 | $0.71 | $671 | 50,020 | SEC↗ |
| Tari Leslie | Chief Scientific Officer | S Sale | 2022-01-05 | 2022-01-07 | 1,252 | $1.25 | $1.6K | 155,400 | SEC↗ |
| Johnson Brady | Vice President, Finance | S Sale | 2022-01-05 | 2022-01-07 | 416 | $1.25 | $520 | 50,965 | SEC↗ |
| Daruwala Paul | Chief Operating Officer | S Sale | 2022-01-05 | 2022-01-07 | 5,133 | $1.25 | $6.4K | 187,298 | SEC↗ |
| Stein Jeffrey | President & CEO | G Gift | 2021-12-31 | 2026-01-07 | 937 | — | $0 | 2,379 | SEC↗ |
| Stein Jeffrey | President & CEO | G Gift | 2021-12-31 | 2026-01-07 | 1,873 | — | $0 | 67,498 | SEC↗ |
| Tari Leslie | Chief Scientific Officer | M Exercise deriv | 2021-12-29 | 2022-01-07 | 2,101 | — | $0 | 1,574 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | M Exercise deriv | 2021-12-29 | 2022-01-07 | 10,000 | — | $0 | 12,500 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | M Exercise deriv | 2021-12-29 | 2022-01-07 | 5,600 | — | $0 | 6,300 | SEC↗ |
| Johnson Brady | Vice President, Finance | M Exercise deriv | 2021-12-29 | 2022-01-07 | 262 | — | $0 | 262 | SEC↗ |
| Stein Jeffrey | President & CEO | M Exercise deriv | 2021-12-29 | 2022-01-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Daruwala Paul | Chief Operating Officer | M Exercise deriv | 2021-12-29 | 2022-01-07 | 4,900 | — | $0 | 5,600 | SEC↗ |
| Daruwala Paul | Chief Operating Officer | M Exercise deriv | 2021-12-29 | 2022-01-07 | 5,000 | — | $0 | 12,500 | SEC↗ |
| Tari Leslie | Chief Scientific Officer | M Exercise | 2021-12-29 | 2022-01-07 | 2,101 | — | $0 | 156,652 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | M Exercise | 2021-12-29 | 2022-01-07 | 15,600 | — | $0 | 256,231 | SEC↗ |
| Johnson Brady | Vice President, Finance | M Exercise | 2021-12-29 | 2022-01-07 | 262 | — | $0 | 51,381 | SEC↗ |
| Stein Jeffrey | President & CEO | M Exercise | 2021-12-29 | 2022-01-07 | 20,000 | — | $0 | 489,878 | SEC↗ |
| Daruwala Paul | Chief Operating Officer | M Exercise | 2021-12-29 | 2022-01-07 | 9,900 | — | $0 | 192,431 | SEC↗ |
| Shah Preetam | CFO & CBO | P Buy | 2021-11-12 | 2021-11-15 | 20,000 | $1.54 | $30.8K | 20,000 | SEC↗ |
| Stein Jeffrey | President & CEO | P Buy | 2021-11-12 | 2021-11-15 | 50,000 | $1.59 | $79.5K | 465,878 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | A Award | 2021-09-30 | 2021-10-04 | 148,000 | — | $0 | 150,551 | SEC↗ |
| Daruwala Paul | Chief Operating Officer | A Award | 2021-09-30 | 2021-10-04 | 132,000 | — | $0 | 182,531 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | A Award | 2021-09-30 | 2021-10-04 | 150,600 | — | $0 | 236,631 | SEC↗ |
| Johnson Brady | Vice President, Finance | A Award | 2021-09-30 | 2021-10-04 | 20,750 | — | $0 | 47,199 | SEC↗ |
| Johnson Brady | Vice President, Finance | A Award | 2021-09-30 | 2021-10-05 | 20,750 | — | $0 | 47,119 | SEC↗ |
| Franson Timothy R | Director | P Buy | 2021-09-13 | 2021-09-14 | 7,000 | $2.12 | $14.8K | 11,000 | SEC↗ |
| Shah Preetam | CFO & CBO | A Award deriv | 2021-09-01 | 2021-09-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Shah Preetam | CFO & CBO | A Award deriv | 2021-09-01 | 2021-09-03 | 311,850 | — | $0 | 311,850 | SEC↗ |
| Ward Shane | CHIEF LEGAL OFFICER | A Award deriv | 2021-08-25 | 2021-08-27 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Stein Jeffrey | President & CEO | P Buy | 2021-08-19 | 2021-08-19 | 10,000 | $1.79 | $17.9K | 415,878 | SEC↗ |
| Stein Jeffrey | President & CEO | P Buy | 2021-08-18 | 2021-08-19 | 40,000 | $1.72 | $68.8K | 405,878 | SEC↗ |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2021-07-30 | 2021-07-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Johnson Brady | Vice President, Finance | A Award deriv | 2021-07-30 | 2021-07-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Bassler Bonnie L | Director | A Award deriv | 2021-06-23 | 2021-06-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| BURGESS DANIEL D | Director | A Award deriv | 2021-06-23 | 2021-06-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Canale-Theakston Carin | Director | A Award deriv | 2021-06-23 | 2021-06-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Mineo Chrysa | Director | A Award deriv | 2021-06-23 | 2021-06-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Schroeder Theodore R | Director | A Award deriv | 2021-06-23 | 2021-06-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Gollaher David L | Director | A Award deriv | 2021-06-23 | 2021-06-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Franson Timothy R | Director | A Award deriv | 2021-06-23 | 2021-06-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Oien Jessica | General Counsel & Secretary | S Sale | 2021-04-01 | 2021-04-05 | 1,177 | $2.66 | $3.1K | 7,764 | SEC↗ |
| Daruwala Paul | Chief Operating Officer | S Sale | 2021-04-01 | 2021-04-05 | 593 | $2.66 | $1.6K | 50,531 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | S Sale | 2021-04-01 | 2021-04-05 | 1,469 | $2.66 | $3.9K | 57,471 | SEC↗ |
| Stein Jeffrey | President & CEO | A Award | 2021-03-31 | 2021-04-05 | 10,000 | — | $0 | 361,878 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | A Award | 2021-03-31 | 2021-04-05 | 700 | — | $0 | 82,031 | SEC↗ |
| Oien Jessica | General Counsel & Secretary | A Award | 2021-03-31 | 2021-04-05 | 2,800 | — | $0 | 8,941 | SEC↗ |
| Daruwala Paul | Chief Operating Officer | A Award | 2021-03-31 | 2021-04-05 | 1,400 | — | $0 | 51,124 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | A Award | 2021-03-31 | 2021-04-05 | 3,500 | — | $0 | 58,940 | SEC↗ |
| Oien Jessica | General Counsel & Secretary | A Award deriv | 2021-03-17 | 2021-03-19 | 135,000 | — | $0 | 135,000 | SEC↗ |
| Sandison Taylor | Chief Medical Officer | A Award deriv | 2021-03-17 | 2021-03-19 | 145,000 | — | $0 | 145,000 | SEC↗ |
| Daruwala Paul | Chief Operating Officer | A Award deriv | 2021-03-17 | 2021-03-19 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | A Award deriv | 2021-03-17 | 2021-03-19 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Levine James E. | Chief Financial Officer | A Award deriv | 2021-03-17 | 2021-03-19 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Stein Jeffrey | President & CEO | A Award deriv | 2021-03-17 | 2021-03-19 | 525,000 | — | $0 | 525,000 | SEC↗ |
| Bassler Bonnie L | Director | A Award deriv | 2021-01-22 | 2021-01-25 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Canale-Theakston Carin | Director | A Award deriv | 2021-01-22 | 2021-01-25 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Oien Jessica | General Counsel & Secretary | S Sale | 2021-01-05 | 2021-04-05 | 824 | $2.06 | $1.7K | 6,141 | SEC↗ |
| Daruwala Paul | Chief Operating Officer | S Sale | 2021-01-05 | 2021-04-05 | 2,868 | $2.06 | $5.9K | 49,724 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | S Sale | 2021-01-05 | 2021-04-05 | 2,868 | $2.06 | $5.9K | 55,440 | SEC↗ |